Inflammation impact on T2DM pathophysiology is even more evident since pro-inflammatory mediators like interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) mediate glucotoxicity effect on pancreatic β-cell dysfunction and increase insulin resistance levels [2,3]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.